[1]
“Clinical Evaluation of T-AYU-HM Premium in Sickle cell Anemia Patients: A Retrospective Study”, Int J Ayu Pharm Res, vol. 10, no. Suppl2, pp. 28–35, Oct. 2022, doi: 10.47070/ijapr.v10iSuppl2.2554.